Olivia Brayer is a seasoned professional in the biotechnology sector, currently serving as Director and Senior Biotech Analyst at Cantor Fitzgerald since April 2022. Prior experience includes the role of Vice President in Equity Research at Bank of America from 2019 to 2022, where Olivia was part of a top-ranked Large Cap Biotech team. Prior to that, positions held at Barclays and Guggenheim Partners involved covering US Pharma and Biotech sectors, with a focus on immuno-oncology at Guggenheim. Olivia holds a Bachelor of Arts in Mathematics and French from Amherst College and completed a study abroad program at Université Paris-Sorbonne.
Sign up to view 0 direct reports
Get started